This document summarizes guidelines for the postnatal management of infants with antenatal hydronephrosis. It discusses the timing of initial ultrasound, grading and diagnosis of postnatal hydronephrosis, postnatal monitoring with repeat ultrasounds, indications for micturating cystourethrogram and diuretic renography, and signs requiring surgical intervention. The main points are to closely monitor infants based on the severity of hydronephrosis and to identify and treat any underlying obstructive causes or loss of renal function.
Management of renal cell carcinoma - presented at Asian Oncology Summit 2013Siewhong Ho
Dr Ho lectured at the Asian Oncology Summit 2013 in Bangkok on the surgical opinion on management of renal cell carcinoma. He presented to a varied audience of medical oncologist, radiation oncologist, urologists, researchers, para clinical staff and nurses. The most interesting aspect of the lecture was on the role of urologists in management of Stage 4 kidney cancer in the era of 'targeted therapy'. The role of cytoreductive nephrectomy was reviewed potential future developments in this area was discussed
Management of renal cell carcinoma - presented at Asian Oncology Summit 2013Siewhong Ho
Dr Ho lectured at the Asian Oncology Summit 2013 in Bangkok on the surgical opinion on management of renal cell carcinoma. He presented to a varied audience of medical oncologist, radiation oncologist, urologists, researchers, para clinical staff and nurses. The most interesting aspect of the lecture was on the role of urologists in management of Stage 4 kidney cancer in the era of 'targeted therapy'. The role of cytoreductive nephrectomy was reviewed potential future developments in this area was discussed
Hello Guys,
This presentation talks about diagnosis and management of Antenatally detected hydronephrosis. We have discussed evidence based fetal hydronephrosis management including - antenatal followup schedule, fetal interventions, postnatal screening and follow up proforma, MCU, Functional renal scans, prophylactic antibiotics and available surgical management options.
POSTERIOR URETHRAL VALVES- Pediatric Surgery
• Dear viewers,
• Greetings from “ Surgical Educator”
• Today I have uploaded one more video in Pediatric Surgery/Pediatric Urology- “ Posterior Urethral Valves”
• Posterior Urethral Valves is the congenital cause for Bladder Outlet Obstruction, resulting in abnormal development of the kidneys as well as the bladder.
• In this video, I talked about the learning outcomes, introduction, etiopathogenesis, clinical features, investigations, differential diagnosis, treatment, follow-up and prognosis of “ Posterior Urethral Valves”
• I hope you will enjoy the video for its educational value.
• You can watch all my teaching videos in the following links
• surgicaleducator.blogspot.com youtube.com/c/surgicaleducator
• Thank you for watching the video.
Hello Guys,
This presentation talks about diagnosis and management of Antenatally detected hydronephrosis. We have discussed evidence based fetal hydronephrosis management including - antenatal followup schedule, fetal interventions, postnatal screening and follow up proforma, MCU, Functional renal scans, prophylactic antibiotics and available surgical management options.
POSTERIOR URETHRAL VALVES- Pediatric Surgery
• Dear viewers,
• Greetings from “ Surgical Educator”
• Today I have uploaded one more video in Pediatric Surgery/Pediatric Urology- “ Posterior Urethral Valves”
• Posterior Urethral Valves is the congenital cause for Bladder Outlet Obstruction, resulting in abnormal development of the kidneys as well as the bladder.
• In this video, I talked about the learning outcomes, introduction, etiopathogenesis, clinical features, investigations, differential diagnosis, treatment, follow-up and prognosis of “ Posterior Urethral Valves”
• I hope you will enjoy the video for its educational value.
• You can watch all my teaching videos in the following links
• surgicaleducator.blogspot.com youtube.com/c/surgicaleducator
• Thank you for watching the video.
Antenatal Hydronephrosis, Hydronephrosis in Child Treatment, Delhi - Dr. Pras...Dr. Prashant Jain
With easy availability of ultrasound screening and improvement in expertise, hydronephrosis is now a very frequently diagnosed problem reported in 1 to 5% of all pregnancies. This has enabled us to have a better understanding of the natural course of the problem and early intervention before it results in permanent renal damage.
The distinction between urinary tract obstruction and dilatation remains a challenging problem for clinicians. Still there are no definite guidelines and protocols for evaluation of antenatal hydronephrosis (ANH).
Vesicoureteric reflux , a common condition in children which could be misdiagnosed . Early diagnosis can help prevent renal scarring and other complications
In this presentation nuclear medicine application in nephrology is explained in detail based on UPTODATE evidence based recommendations.
Different examples were given.
Ureteropelvic junction obstruction by\ Eman Salman
It was used for student presentation in Urology course rotation
I Hope you find what is helpful for your knowledge ♥
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
5. Timing of initial
ultrasound:
Recommendations
Post natal ultrasound within first week of life.
In neonates with suspected posterior urethral valves,
oligohydramnios or severe bilateral hydronephrosis,
ultrasonography should be performed within 24-
48hours of birth.
In all other cases, the ultrasound should be performed
preferably within 3-7 days, or before hospital discharge.
All newborns with a history of ANH, including those in
whom it had resolved prenatally, should also undergo
postnatal evaluation. (usually have better prognosis)
6. • It is emphasized that an ultrasound in the first few days of life under-
estimates the degree of pelvic dilatation due to dehydration and a
relatively low urine output.
• In others, the first ultrasound examination should ideally be delayed until
the end of first week.
• Despite this limitation, an early ultrasound, within 24-48 hr of birth, is
necessary in neonates with suspected
• lower urinary tract obstruction
• Oligohydramnios
• bilateral severe hydronephrosis
• severe hydronephrosis in a solitary kidney
7. Diagnosis and
grading of postnatal
hydronephrosis:
Recommendations
Assessment of severity of postnatal
hydronephrosis be based on the
classification proposed by Society
for Fetal Urology or anteroposterior
diameter of the renal pelvis.
Ultrasonography should include
evaluation for calyceal or ureteric
dilation, cortical cysts and enhanced
renal echogenicity, and bladder wall
abnormalities.
8. 1) Degree of pelvic dilatation, 2) No of calyces seen,
3)+ & severity of parenchymal atrophy
9. • Neonatal hydronephrosis is defined as SFU grade ≥1 or renal APD ≥7
mm.
• A systematic review concluded that 98% patients with SFU grade 1-2
or APD <12 mm resolved, compared to 51% with APD >12 mm or SFU
3-4.
• Grading the severity of hydronephrosis enables identification of
infants that require close follow-up.
10. • The presence of calyceal and/or ureteric dilatation has high (87-96%)
specificity but low sensitivity (37-54%) for detecting grade III-V VUR.
• Increased parenchymal echogenicity, loss of corticomedullary
differentiation and presence of cortical cysts on postnatal ultrasound
predict impaired renal function or dysplasia in patients with
pelviureteric obstruction and posterior urethral valves.
11. Postnatal
monitoring:
Recommendations
Neonates with normal ultrasound
examination in the first week of life
should undergo a repeat study at 4-6
weeks.
Infants with isolated mild unilateral or
bilateral hydronephrosis (APD <10 mm
or SFU grade 1-2) should be followed
by sequential ultrasound alone, for
resolution or progression of findings.
12. • A single ultrasound in the first week of life might not detect all
abnormalities of the kidneys or urinary tract, due to low urine flow
secondary to dehydration and low glomerular filtration rate.
• An ultrasound at 6 weeks is more sensitive and specific for
obstruction, than that in the first week of life.
• All newborns with a normal ultrasound at first week, therefore,
require a repeat study at 4-6 weeks.
• The presence of two normal postnatal renal ultrasounds excludes
presence of significant renal disease including dilating VUR.
13. • The frequency of subsequent monitoring in patients with persistent
postnatal hydronephrosis depends on its severity, and includes
evaluation for increasing pelvicalyceal or ureteric dilatation and
cortical thinning.
• Since progression might occur in the first 2-years of life, and
occasionally until 5-6 years, follow up studies are scheduled at 3- and
6-months, and then 6-12 monthly until resolution.
14. Micturating
cystourethrogram:
Recommendations
Micturating cystourethrogram (MCU) should be
performed in patients with unilateral or bilateral
hydronephrosis with renal pelvic APD >10mm, SFU
grade 3-4 or ureteric dilatation.
MCU should be performed early, within 24-72 hours of
life, in patients with suspected lower urinary tract
obstruction.
In other cases, the procedure should be done at 4-6
weeks of age.
MCU is recommended for infants with antenatally
detected hydronephrosis who develop a urinary tract
infection.
15. • Lower urinary tract obstruction (most commonly posterior urethral
valves in boys; occasionally bilateral ureteroceles) is an important
cause of ANH and requires prompt management.
• Ultrasonographic findings of posterior urethral valves are:
• bilateral hydroureteronephrosis,
• dilated, thick walled bladder that fails to empty
• dilated posterior urethra.
• These patients are at risk for progressive kidney disease and recurrent
UTI.
• Early MCU (within 1-3 days of life) enables prompts intervention.
16. • VUR is present in 8-38% patients with unilateral or bilateral ANH, as
compared to <1% in the general population.
• Multiple studies and a systematic review suggest that the severity of
ANH does not correlate with the grade of reflux.
• So, renal pelvic APD exceeding 10-11 mm is useful in identifying
patients with severe VUR with the help of MCU.
17. • Pelviureteric junction obstruction should be considered in infants
with hydronephrosis, where dilating VUR is excluded.
• Possibility of vesico-ureteric junction obstruction or megaureter is
considered in patients with hydronephrosis and dilated ureter where
MCU is normal.
• Patients with VUR and worsening hydronephrosis also require
evaluation for pelvi-ureteric junction obstruction, since the two may
coexist in 7-18% patients.
18. Diuretic
renography:
Recommendations
• Infants with moderate to severe unilateral or bilateral
hydronephrosis (SFU grade 3-4, APD >10 mm) who do not
show VUR should undergo diuretic renography.
• Infants with hydronephrosis and dilated ureter(s) and no
evidence of VUR undergo diuretic renography.
• The preferred radiopharmaceuticals are:
• 99m Tc mercapto-acetyltriglycine(MAG3)
• ethylenedicysteine(Tc-EC)
• Tc-diethylene triamine pentaacetic acid (DTPA).
• The differential function is estimated and renogram curve
inspected for pattern of drainage.
• Diuretic renography be performed after 6-8 weeks of age.
• The procedure may be repeated after 3-6 months in infants
where ultrasound shows worsening of pelvicalyceal
dilatation.
19. • Diuretic renography allows differentiation between obstructive and
non-obstructive hydronephrosis and estimating relative renal
function.
• Radiopharmaceuticals such as 99m-Tc MAG3 or EC are preferred,
since they show greater renal extraction and higher kidney to
background ratio compared to DTPA.
• However, DTPA is inexpensive and widely available.
20. • Since immaturity of renal function results in reduced radiotracer
uptake, renography is done at 6-8 weeks of life but may be performed
earlier in patients with severe hydronephrosis and cortical thinning.
23. • A normal renogram curve is characterized by an early peak (2-5
minutes), rapidly descending phase and almost complete renal
emptying by 20 minutes.
• The presence of satisfactory drainage spontaneously, or following IV
frusemide and micturition excludes significant obstruction.
• An obstructive pattern is defined by an ascending or plateau phase
over 20minutes, that fails to empty following diuretic administration
and on post-micturition views.
24. • Differential renal function is estimated; values between 45% and 55%
are considered normal.
• An initial differential function below 35-40% in the kidney with
obstructed drainage signifies impaired function.
• Other features that suggest obstruction include ipsilateral supra-
normal differential renal function(≥55%) and prolonged time to clear
50% of the radionuclide (t1/2 >20 minutes).
25. Indications for
surgery:
Recommendations
Infants with lower urinary tract obstruction be
immediately referred to a surgeon for
appropriate intervention.
Surgery should be considered in patients with
obstructed hydronephrosis, and either reduced
differential renal function or its worsening on
repeat evaluation.
Surgery should be considered in patients with
bilateral hydronephrosis or hydronephrosis in
solitary kidney showing worsening dilatation
and deterioration of function.
26. • Infants with posterior urethral valves require
• early urethral catheterization
• correction of electrolyte abnormalities
• treatment for possible complications
• referral for surgical intervention
• Cystoscopic ablation of the urethral valves is recommended.
• If cystoscopic ablation is not possible, then vesicostomy is performed.
27. • Pyeloplasty be considered in patients showing obstructed drainage
and differential function below 40%.
• Conservative management is considered for infants with an
obstructive pattern on diuretic renography and differential function
exceeding 40%.
• Serial ultrasonography is recommended and repeat renography done if there
is persistent or progressive hydronephrosis or parenchymal thinning.
• A reduction of differential renal function by more than 5-10%
correlates with declining renal function, and the need for pyeloplasty.
28. • Other indications for surgery include:
• presence of pain
• palpable renal lump
• recurrent febrile UTI
• The presence of large APD exceeding 20-30 mm predicts the need for
surgery.
29. • In cases of megaureter or vesicoureteric junction obstruction, end
ureterostomy is considered and later ureteric reimplantation is done
during preschool period.
• In cases of vesicoureteric reflux, antibiotic prophylaxis is
recommended till age of three years as these children are at
increased risk of UTI.
• If VUR is worsening or there are episodes of breakthrough UTIs,
surgical intervention is recommended. This includes ureteric
reimplantation surgery. Lower grades VUR can be managed by deflux
injections.